Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
Open accessThe DOI matches its Crossref record; 537 of the 537 references it cites were found in a registry or an index.
Abstract
Colorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide. Its complexity is influenced by various signal transduction networks that govern cellular proliferation, survival, differentiation, and apoptosis. The pathogenesis of CRC is a testament to the dysregulation of these signaling cascades, which culminates in the malignant transformation of colonic epithelium. This review aims to dissect the foundational signaling mechanisms implicated in CRC, to elucidate the generalized principles underpinning neoplastic evolution and progression. We discuss the molecular hallmarks of CRC, including the genomic, epigenomic and microbial features of CRC to highlight the role of signal transduction in the orchestration of the tumorigenic process. Concurrently, we review the advent of targeted and immune therapies in CRC, assessing their impact on the current clinical landscape. The development of these therapies has been informed by a deepening understanding of oncogenic signaling, leading to the identification of key nodes within these networks that can be exploited pharmacologically. Furthermore, we explore the potential of integrating AI to enhance the precision of therapeutic targeting and patient stratification, emphasizing their role in personalized medicine. In summary, our review captures the dynamic interplay between aberrant signaling in CRC pathogenesis and the concerted efforts to counteract these changes through targeted therapeutic strategies, ultimately aiming to pave the way for improved prognosis and personalized treatment modalities in colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, HER2 is commonly amplified or overexpressed in 7% to 47.4% of CRC patients, activating downstream signaling in a similar manner [81–83].”
From Differential Response and Resistance to KRAS-Targeted Therapy (2025) · cites this paper as [81]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–537 of 537
Terasaki, H., Saitoh, T., Shiokawa, K., & Katoh, M. (2002) · International Journal of Molecular Medicine · doi:10.3892/ijmm.9.2.107 · Cited by 69
High levels of DNA adducts in human colon are associated with colorectal cancer.
Pfohl‐Leszkowicz, A., Grosse, Y., Carrière, V., Cugnenc, P., Berger, A., Carnot, F., Beaune, P. H., & de Waziers, I. (1995) · PubMed · Cited by 68
Rahma, O. E., Hamilton, J. M., Wojtowicz, M., Dakheel, O., Bernstein, S., Liewehr, D. J., Steinberg, S. M., & Khleif, S. N. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-55 · Cited by 67
Shimada, Y., Okuda, S., Watanabe, Y., Tajima, Y., Nagahashi, M., Ichikawa, H., Nakano, M., Sakata, J., Takii, Y., Kawasaki, T., et al. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01789-w · Cited by 67
Yang, X., Zeng, Z., Hou, Y., Yuan, T., Gao, C., Jia, W., Yi, X., & Liu, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088745 · Cited by 66
Novel Circulating Tumor Cell Assay for Detection of Colorectal Adenomas and Cancer
Tsai, W., You, J., Hung, H., Hsieh, P., Hsieh, B. R., Lenz, H., Idos, G., Friedland, S., Pan, J. Y.-J., Shao, H., et al. (2019) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000088 · Cited by 66
You, S., Zhou, J., Chen, S., Zhou, P., Lv, J., Han, X., & Sun, Y. (2010) · Upsala Journal of Medical Sciences · doi:10.3109/03009731003668316 · Cited by 65
Shia, J. (2015) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2015.02.018 · Cited by 63
Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance
Solomon, I., Harrington, E., Hooker, G., Erby, L., Axilbund, J., Hampel, H., Semotiuk, K., Blanco, A., Klein, W. M. P., Giardiello, F., et al. (2017) · Journal of Genetic Counseling · doi:10.1007/s10897-017-0066-y · Cited by 63
Shiromizu, T., Kume, H., Ishida, M., Adachi, J., Kano, M., Matsubara, H., & Tomonaga, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-13092-x · Cited by 63
Cole, A., Murray, S. S., & Xiao, J. (2016) · Stem Cells International · doi:10.1155/2016/9260592 · Cited by 63
Ganig, N., Baenke, F., Thepkaysone, M.-L., Lin, K., Rao, V. S., Wong, F. C., Polster, H., Schneider, M., Helm, D., Pecqueux, M., et al. (2021) · Cancers · doi:10.3390/cancers13061351 · Cited by 63
Snook, A. E., Baybutt, T. R., Xiang, B., Abraham, T. S., Flickinger, J. C., Hyslop, T., Zhan, T., Kraft, W. K., Sato, T., & Waldman, S. A. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0576-2 · Cited by 62
Nivolumab in the Treatment of Microsatellite Instability High Metastatic Colorectal Cancer
Sarshekeh, A. M., Overman, M. J., & Kopetz, S. (2018) · Future Oncology · doi:10.2217/fon-2017-0696 · Cited by 60
Bao, X., Li, Q., Chen, D., Dai, X., Liu, C., Tian, W., Zhang, H., Jin, Y., Wang, Y., Cheng, J., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101399 · Cited by 59
Self-citationJohnson, B., Haymaker, C., Parra, E. R., Soto, L. M. S., Wang, X., Thomas, J. V., Dasari, A. N., Morris, V. K., Raghav, K. P. S., Vilar, E., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005332 · Cited by 59
Integrated multi-omics characterization of KRAS mutant colorectal cancer
Chong, W., Zhu, X., Ren, H., Ye, C., Xu, K., Wang, Z., Jia, S., Shang, L., Li, L., & Chen, H. (2022) · Theranostics · doi:10.7150/thno.73089 · Cited by 58
Immunogenicity of pembrolizumab in patients with advanced tumors
van Vugt, M. J. H., Stone, J. A., De Greef, “. H. J. M. M., Snyder, E. S., Lipka, L., Turner, D. C., Chain, A., Lala, M., Li, M., Robey, S. H., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0663-4 · Cited by 57
Marie, P. K., Haymaker, C., Parra, E. R., Kim, Y. U., Lazcano, R., Gite, S., Lorenzini, D., Wistuba, I. I., Tidwell, R. S. S., Song, X., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0163 · Cited by 57
Hu, M., Fu, X., Si, Z., Li, C., Sun, J., Du, X., & Zhang, H. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01245 · Cited by 57
Martínez-Romero, M., Vázquez-Naya, J. M., Rabuñal, J. R., Pita‐Fernández, S., Macenlle, R., Alvariño, J. C., López-Rosés, L., Ulla, J. L., Martinez-Calvo, A. V., Vazquez, S., et al. (2010) · Current Drug Metabolism · doi:10.2174/138920010791514289 · Cited by 57
Takei, N., Yoneda, A., Sakai-Sawada, K., Kosaka, M., Minomi, K., & Tamura, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-09976-7 · Cited by 56
CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal Phenotype
Lal, S., Cheung, E. C., Zarei, M., Preet, R., Chand, S. N., Mambelli-Lisboa, N. C., Romeo, C., Stout, M. C., Londin, E. R., Goetz, A. B., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0361 · Cited by 56
Berek, J. S., Edwards, R. P., Parker, L. P., DeMars, L. R., Herzog, T. J., Lentz, S. S., Morris, R. T., Akerley, W., Holloway, R. W., Method, M. W., et al. (2014) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000286 · Cited by 56
Balint, J. P., Gabitzsch, E. S., Rice, A., Latchman, Y., Xu, Y., Messerschmidt, G. L., Chaudhry, A., Morse, M. A., & Jones, F. R. (2015) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-015-1706-4 · Cited by 56
Implications of the growing incidence of global colorectal cancer
Vabi, B. W., Gibbs, J. F., & Parker, G. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-2019-gi-06 · Cited by 55
Xie, J., Lin, L., Huang, X., Gan, R.-H., Ding, L.-C., Su, B.-H., Zhao, Y., Lu, Y., & Zheng, D. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.36407 · Cited by 54
Liyanage, N. P. M., Manthey, K. C., Dassanayake, R. P., KUSZYNSKI, C. A., Oakley, G. G., & Duhamel, G. E. (2010) · Helicobacter · doi:10.1111/j.1523-5378.2010.00749.x · Cited by 53
Recent advances in CAR-T cells therapy for colorectal cancer
Qin, X., Wu, F., Chen, C., & Li, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.904137 · Cited by 53
Self-citationLü, Z., Chen, H., Jiao, X., Zhou, W., Han, W., Li, S., Liu, C. X., Gong, J., Li, J., Zhang, X., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000631 · Cited by 52
Torrezan, G. T., da Silva, F. C. C., Santos, É. M. M., Krepischi, A. C. V., Achatz, M. I., Aguiar, S., Rossi, B. M., & Carraro, D. M. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-54 · Cited by 52
USP38 regulates the stemness and chemoresistance of human colorectal cancer via regulation of HDAC3
Zhan, W., Liao, X., Liu, J., Tian, T., Yu, L., & Li, R. (2020) · Oncogenesis · doi:10.1038/s41389-020-0234-z · Cited by 51
Oh, C. R., Kim, J. E., Hong, Y. S., Kim, S. Y., Ahn, J. B., Baek, J. Y., Lee, M. A., Kang, M. J., Cho, S., Beom, S., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.33966 · Cited by 51
Danese, E., Montagnana, M., & Lippi, G. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.08.97 · Cited by 51
Myh Deficiency Enhances Intestinal Tumorigenesis in Multiple Intestinal Neoplasia ( Apc Min /+) Mice
Sieber, O. M., Howarth, K. M., Thirlwell, C., Rowan, A., Mandir, N., Goodlad, R. A., Gilkar, A., Spencer-Dene, B., Stamp, G., Johnson, V., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2958 · Cited by 49
Brocco, D., Simeone, P., Buca, D., Marino, P. D., Tursi, M. D., Grassadonia, A., Lellis, L. D., Martino, M. T., Veschi, S., Iezzi, M., et al. (2022) · Cancers · doi:10.3390/cancers14051357 · Cited by 49
Li, S., Han, Z., Zhao, N., Zhu, B., Zhang, Q., Yang, X., Sheng, D., Hou, J., Guo, S., Wei, L., et al. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.03.014 · Cited by 48
Aldea, M., Friboulet, L., Apcher, S., Jaulin, F., Mosele, F., Sourisseau, T., Soria, J.-C., Nikolaev, S., & André, F. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.101642 · Cited by 47
Wang, C., Park, J., Ouyang, C., Longmate, J., Tajon, M., Chao, J., Lim, D. W., Sandhu, J. S., Yin, H. H., Pillai, R. K., et al. (2019) · The Oncologist · doi:10.1634/theoncologist.2019-0924 · Cited by 47
Racial and Ethnic Disparities in Colorectal Cancer Screening and Outcomes
McLeod, M. R., Galoosian, A., & May, F. P. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.02.003 · Cited by 46
Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer
Vedeld, H. M., Nesbakken, A., Lothe, R. A., & Lind, G. E. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0503-2 · Cited by 46
Sun, Z., Ji, S., Wu, J., Tian, J., Quan, W., Shang, A., Ji, P., Xiao, W., Liu, D., Wang, X., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.725211 · Cited by 45
Lucchetti, D., Zurlo, I. V., Colella, F., Tenore, C. R., Salvatore, M. D., Tortora, G., Maria, R. D., Giuliante, F., Cassano, A., Basso, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-01668-7 · Cited by 45
Nivolumab in Renal Cell Carcinoma: Current Trends and Future Perspectives
Ochoa, C. E., & Joseph, R. W. (2018) · Journal of Kidney Cancer and VHL · doi:10.15586/jkcvhl.2018.102 · Cited by 45
Chen, Y., Yu, Z., Lv, M., Cai, Z., Zou, Y., Lan, P., Wu, X., & Gao, F. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00402-3 · Cited by 43
Šuštić, T., van Wageningen, S., Bosdriesz, E., Reid, R. J. D., Dittmar, J., Lieftink, C., Beijersbergen, R. L., Wessels, L. F. A., Rothstein, R., & Bernards, R. (2018) · Genome Medicine · doi:10.1186/s13073-018-0600-z · Cited by 42
Song, M., Qian, C., Zhang, T., Tang, Y. R., Zhou, Y., Wei, Z., Wang, A., Zhong, C., Zhao, Y., & Lu, Y. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116735 · Cited by 42
Synergism of PI3K/Akt inhibition and Fas activation on colon cancer cell death
Zhu, L., Dérijard, B., Chakrabandhu, K., Wang, B., Chen, H., & Hueber, A. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.08.038 · Cited by 42
Xia, D., Ji, W., Xu, C., Lin, X., Wang, X., Xia, Y., Lv, P., Song, Q., Ma, D., & Chen, Y. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.347 · Cited by 42
Kim, N., Cho, D., Kim, H., Kim, S., Cha, Y., Greulich, H. E., Bass, A. J., Cho, H., & Cho, J. (2019) · International Journal of Cancer · doi:10.1002/ijc.32499 · Cited by 42
Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis families
Kanter-Smoler, G., Fritzell, K., Rohlin, A., Engwall, Y., Hallberg, B., Bergman, A., Meuller, J., Grönberg, H., Karlsson, P., Björk, J. A., et al. (2008) · BMC Medicine · doi:10.1186/1741-7015-6-10 · Cited by 42
Deihimi, S., Lev, A., Slifker, M. J., Shagisultanova, E. I., Xu, Q., Jung, K., Vijayvergia, N., Ross, E. A., Xiu, J., Swensen, J. J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18098 · Cited by 42
Identification of biomarkers for colorectal cancer through proteomics-based approaches
Tjalsma, H. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.81 · Cited by 41
Artificial Neural Network for Prediction of Distant Metastasis in Colorectal Cancer
Biglarian, A., Bakhshi, E., Gohari, M. R., & Khodabakhshi, R. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.3.927 · Cited by 41
Li, H., Zhao, L., Lau, Y. S., Zhang, C., & Han, R. (2020) · Oncogene · doi:10.1038/s41388-020-01523-5 · Cited by 41
Oh, S., You, E., Ko, P., Jeong, J., Keum, S., & Rhee, S. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.039 · Cited by 41
Yao, M., Li, R., Yang, Z., Ding, Y., Zhang, W., Li, W., Liu, M., Zhao, C., Wang, Y., Tang, H., et al. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109246 · Cited by 41
Jia, L.-L., Zheng, Q., Tian, J., He, D.-L., Zhao, J.-X., Zhao, L., & Huang, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1026216 · Cited by 41
Niinuma, T., Kitajima, H., Kai, M., Yamamoto, E., Yorozu, A., Ishiguro, K., Sasaki, H., Sudo, G., Toyota, M., Hatahira, T., et al. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0668-3 · Cited by 41
Granata, V., Fusco, R., Muzio, F. D., Cutolo, C., Raso, M. M., Gabelloni, M., Avallone, A., Ottaiano, A., Tatangelo, F., Brunese, M. C., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12051115 · Cited by 41
Endo, E., Okayama, H., Saito, K., Nakajima, S., Yamada, L., Ujiie, D., Kase, K., Fujita, S., Endo, H., Sakamoto, W., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0308 · Cited by 40
Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies
Aitken, A. S., Roy, D. G., & Bourgeois‐Daigneault, M. (2017) · Biomedicines · doi:10.3390/biomedicines5010003 · Cited by 40
Herting, C. J., Farren, M. R., Tong, Y., Liu, Z., O’Neil, B. H., Bekaii‐Saab, T., Noonan, A. M., McQuinn, C. W., Mace, T. A., Shaib, W. L., et al. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02986-5 · Cited by 39
Promising Epigenetic Biomarkers for the Early Detection of Colorectal Cancer: A Systematic Review
Anghel, S. A., Ioniță-Mîndrican, C.-B., Luca, I., & Pop, A. L. (2021) · Cancers · doi:10.3390/cancers13194965 · Cited by 38
Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?
Hu, L., Lan, H., Huang, D., Li, X., & Jin, K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.769305 · Cited by 38
Chakroborty, D., Goswami, S., Fan, H., Frankel, W. L., Basu, S., & Sarkar, C. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01916-1 · Cited by 38
Español‐Rego, M., Fernández-Martos, C., Élez, E., Foguet, C., Pedrosa, L., Rodríguez, N., Ruiz‐Casado, A., Pineda, E., Cid, J., Cabezón, R., et al. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03283-5 · Cited by 36
Role of exosomal miRNA in chemotherapy resistance of Colorectal cancer: A systematic review
Maleki, M., Golchin, A., Javadi, S., Khelghati, N., Morovat, P., Asemi, Z., Alemi, F., Vaghari‐Tabari, M., Yousefi, B., & Majidinia, M. (2021) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13947 · Cited by 35
PI3K/Akt/YAP signaling promotes migration and invasion of DLD‑1 colorectal cancer cells
Takeda, T., Yamamoto, Y., Tsubaki, M., Matsuda, T., Kimura, A., Shimo, N., & Nishida, S. (2022) · Oncology Letters · doi:10.3892/ol.2022.13226 · Cited by 34
Price, T., Ang, A., Boedigheimer, M., Kim, T. W., Li, J., Cascinu, S., Ruff, P., Satya Suresh, A., Thomas, A., Tjulandin, S., et al. (2020) · Cancer Biology & Therapy · doi:10.1080/15384047.2020.1798695 · Cited by 33
Lu, X., Li, Y., Li, Y., Zhang, X., Shi, J., Feng, H., Yu, Z., & Gao, Y. (2023) · BMC Cancer · doi:10.1186/s12885-023-11600-z · Cited by 33
Identifying potential DNA methylation markers in early-stage colorectal Cancer
Zhang, X., Wan, S., Yu, Y., Ruan, W., Wang, H., Xu, L., Wang, C., Chen, S., Cao, T., Peng, Q., et al. (2020) · Genomics · doi:10.1016/j.ygeno.2020.06.007 · Cited by 33
Luo, S., Ru, J., Mirzaei, M. K., Xue, J., Peng, X., Ralser, A., Mejías‐Luque, R., Gerhard, M., & Deng, L. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2257291 · Cited by 33
Shaik, J. P., Alanazi, I. O., Pathan, A. A. K., Parine, N. R., Almadi, M. A., Azzam, N. A., Aljebreen, A., Alharbi, O., Alanazi, M. S., & Khan, Z. (2020) · Journal of Oncology · doi:10.1155/2020/6768942 · Cited by 33
Sheng, J., Wu, J., Yin, X., Sun, Z., Wang, X., Zhang, J., Tang, J., Ji, Y., Song, J., Wei, X., et al. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.08.018 · Cited by 32
Self-citationTang, J., Sheng, J., Zhang, Q., Ji, Y., Wang, X., Zhang, J., Wu, J., Song, J., Bai, X., & Liang, T. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006119 · Cited by 32
Self-citationNgamkham, J., Thuwajit, C., Thuwajit, P., Khamwachirapithak, P., Lertsuwan, K., Charoensawan, V., & Jitrapakdee, S. (2020) · Anticancer Research · doi:10.21873/anticanres.14649 · Cited by 32
McCann, K. J., Mander, A., Cazaly, A. M., Chudley, L., Stasakova, J., Thirdborough, S. M., King, A., Lloyd-Evans, P., Buxton, E., Edwards, C., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2507 · Cited by 31
Cho, J., Bass, A. J., Lawrence, M. S., Cibulskis, K., Cho, A., Lee, S.-N., Yamauchi, M., Wagle, N., Pochanard, P., Kim, N., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-141 · Cited by 31
Ye, Y., Jiao, H., Wang, S., Xiao, Z., Zhang, D., Qiu, J., Zhang, L., Zhao, Y., Li, T., Li-Liang, et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0958-1 · Cited by 31
Nieminen, T. T., Pavicic, W. H., Porkka, N., Kankainen, M., Järvinen, H., Lepistö, A., & Peltomäki, P. (2016) · Oncotarget · doi:10.18632/oncotarget.12206 · Cited by 31
Efficacy and immune-related adverse event associations in avelumab-treated patients
Kelly, K. L., Manitz, J., Patel, M. R., D’Angelo, S. P., Apolo, A. B., Rajan, A., Kasturi, V., Speit, I., Bajars, M., Warth, J. D., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001427 · Cited by 29
Etienne-Grimaldi, M.-C., Mahamat, A., Chazal, M., Laurent‐Puig, P., Olschwang, S., Gaub, M.-P., Formento, J. L., Formento, P., Sudaka, A., Boige, V., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.213 · Cited by 28
Multi-omics analysis to identify susceptibility genes for colorectal cancer
Yuan, Y., Bao, J., Chen, Z., Díez-Villanueva, A., Wen, W., Wang, F., Zhao, D., Fu, X., Cai, Q., Long, J., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab021 · Cited by 28
Zheng, R., Gao, D., He, T., Zhang, M., Zhang, X., Linghu, E., Wei, L., & Guo, M. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0348-0 · Cited by 28
Conradi, L., Spitzner, M., Metzger, A.-L. C., Kisly, M., Middel, P., Bohnenberger, H., Gaedcke, J., Ghadimi, M. B., Liersch, T., Rüschoff, J., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-6051-0 · Cited by 28
Nestarenkaitė, A., Fadhil, W., Rasmusson, A., Susanti, S., Hadjimichael, E., Laurinavičienė, A., Ilyas, M., & Laurinavičius, A. (2020) · Cancers · doi:10.3390/cancers12102902 · Cited by 28
CT colonography: computer-assisted detection of colorectal cancer
Robinson, C., Halligan, S., Iinuma, G., Topping, W., Punwani, S., Honeyfield, L., & Taylor, S. A. (2011) · British Journal of Radiology · doi:10.1259/bjr/17848340 · Cited by 28
Plattner, C., Lamberti, G., Blattmann, P., Kirchmair, A., Rieder, D., Loncova, Z., Sturm, G., Scheidl, S., Ijsselsteijn, M., Fotakis, G., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108399 · Cited by 27
Nagaraju, G. P., Wu, C. S.-Y., Merchant, N., Chen, Z., Lesinski, G. B., & El‐Rayes, B. F. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.021 · Cited by 27
Prossomariti, A., Piazzi, G., D’Angelo, L., Miccoli, S., Turchetti, D., Alquati, C., Montagna, C., Bazzoli, F., & Ricciardiello, L. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0115 · Cited by 27
Lin, K., Baenke, F., Lai, X., Schneider, M. A., Helm, D., Polster, H., Rao, V. S., Ganig, N., Wong, F. C., Seifert, L., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01562-4 · Cited by 27
Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer
Chen, L., Wang, Y., Cai, C., Ding, Y., Kim, R. S., Lipchik, C., Gavin, P. G., Yothers, G., Allegra, C. J., Petrelli, N. J., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.01080 · Cited by 26
Genetic alterations shaping tumor response to anti-EGFR therapies
Vaquero, J., Pavy, A., Gonzalez‐Sanchez, E., Meredith, M., Arbelaiz, A., & Fouassier, L. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100863 · Cited by 26
Automated Classification and Segmentation in Colorectal Images Based on Self‐Paced Transfer Network
Yao, Y., Gou, S., Ru, T., Zhang, X., & He, S. (2021) · BioMed Research International · doi:10.1155/2021/6683931 · Cited by 26
Gögenur, M., Balsevicius, L., Bulut, M., Colak, N. Ö., Justesen, T. F., Fiehn, A. K., Jensen, M. B., Høst-Rasmussen, K., Cappelen, B., Gaggar, S., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-006774 · Cited by 25
Yadav, A., Kumar, A. J., & Siddiqui, M. H. (2021) · World Journal of Clinical Oncology · doi:10.5306/wjco.v12.i12.1169 · Cited by 25
Identification of Spatial Proteomic Signatures of Colon Tumor Metastasis
Levy, J., Zavras, J. P., Veziroglu, E. M., Nasir-Moin, M., Kolling, F., Christensen, B. C., Salas, L. A., Barney, R. E., Palisoul, S. M., Ren, B., et al. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.02.020 · Cited by 25
Shao, W., Zuo, Y., Shi, Y., Wu, Y., Tang, J., Zhao, J., Sun, L., Lu, Z., Sheng, J., Zhu, Q., et al. (2023) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2023.3274652 · Cited by 24
Self-citationZhou, R., Xie, F., Liu, K., Zhou, X., Chen, X., Chen, J., Xi, S., Huang, Z., & Rong, X. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01290-y · Cited by 24
Shrestha, K. S., Aska, E.-M., Tuominen, M. M., & Kauppi, L. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103178 · Cited by 23
A New Story of the Three Magi: Scaffolding Proteins and lncRNA Suppressors of Cancer
Kotelevets, L., & Chastre, E. (2021) · Cancers · doi:10.3390/cancers13174264 · Cited by 23
Exploration of Circulating Tumour Cell (CTC) Biology: A Paradigm Shift in Liquid Biopsy
Chauhan, A., Kaur, R., Ghoshal, S., & Pal, A. (2020) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-020-00923-4 · Cited by 22
Seo, A. N., Kwak, Y., Kim, W. H., Kim, D., Kang, S., Choe, G., & Lee, H. S. (2015) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-015-1747-2 · Cited by 22
HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway
Li, X., Huang, Q., Wang, S., Huang, Z., Yu, F., & Lin, J. (2020) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmaa004 · Cited by 22
Chang, L., Hsu, Y., Chiu, H., Ueda, K., Wu, M., Kao, C., & Shen, T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.732743 · Cited by 22
State of machine and deep learning in histopathological applications in digestive diseases
Kobayashi, S., Saltz, J. H., & Yang, V. W. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i20.2545 · Cited by 22
Savio, A. J., Mrkonjic, M., Lemire, M., Gallinger, S., Knight, J. A., & Bapat, B. V. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0326-6 · Cited by 21
Devoto, L., Ganeshan, B., Keller, D. S., Groves, A. M., Endozo, R., Arulampalam, T., & Chand, M. (2022) · European Journal of Radiology Open · doi:10.1016/j.ejro.2022.100415 · Cited by 20
Application of Deep Learning in Cancer Prognosis Prediction Model
Zhang, H., Xi, Q., Zhang, F., Li, Q., Jiao, Z., & Ni, X. (2023) · Technology in Cancer Research & Treatment · doi:10.1177/15330338231199287 · Cited by 19
Self-citationExpanded targeting scope of LbCas12a variants allows editing of multiple oncogenic mutations
Choi, E., Hwang, H.-Y., Kwon, E., Kim, D., & Koo, T. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.09.005 · Cited by 19
Kawamura, J., Sugiura, F., Sukegawa, Y., Yoshioka, Y., Hida, J., Hazama, S., & Okuno, K. (2018) · Cancer Science · doi:10.1111/cas.13547 · Cited by 19
Pu, W., Qian, F., Liu, J., Shao, K., Xiao, F., Jin, Q., Liu, Q., Jiang, S., Zhang, R., Zhang, J., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.759813 · Cited by 18
Yang, C., Hsu, H., Liu, Y., Tsai, W., Ma, C., Chen, Y., Tan, B. C., Lai, Y., Chang, I. Y., Yang, C., et al. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00688-3 · Cited by 17
FAPP2 promotes tumor cell growth in human colon cancer through activation of Wnt signaling
Chen, J., Li, L., Zhou, Z., Yu, S., Li, Y., & Gao, Y. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.11.002 · Cited by 17
Wen, Y., Ling, S., Liu, R., Pan, Z., Wang, G., Gao, S., Wu, J., Cao, L., Dong, L., Li, Y., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5073 · Cited by 17
Msh2 deficiency increases the mutation frequency in all parts of the mouse colon
Zhang, S., Lloyd, R., Bowden, G. D., Glickman, B. W., & de Boer, J. G. (2002) · Environmental and Molecular Mutagenesis · doi:10.1002/em.10113 · Cited by 16
Li, Y., Li, X., Qu, J., Luo, D., & Hu, Z. M. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s225556 · Cited by 16
García‐Foncillas, J., Bokemeyer, C., Italiano, A., Keating, K. N., Paracha, N., Fellous, M. M., Marian, M., Fillbrunn, M. K., Gao, W., Ayyagari, R., et al. (2022) · Cancers · doi:10.3390/cancers14071793 · Cited by 16
Making Sense of HDAC2 Mutations in Colon Cancer
Mariadason, J. M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.039 · Cited by 14
Güneş, S., Soykan, M. N., Sarıboyacı, A. E., Uysal, O. K., & Sevimli, T. S. (2021) · Medical Oncology · doi:10.1007/s12032-021-01595-7 · Cited by 14
Ye, J., Zhang, J., & Ding, W. (2024) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2024.00203 · Cited by 14
Mori, M., Hirakawa, K., Ohira, M., Sawada, T., INOUE, H. K., Nagahara, H., Mimori, K., & Zhang, X. (2008) · Oncology Reports · doi:10.3892/or.19.6.1541 · Cited by 14
Zhou, Y., Guo, Y., & Wang, Y. (2022) · IET Systems Biology · doi:10.1049/syb2.12041 · Cited by 13
The Prevalence and Molecular Landscape of Lynch Syndrome in the Affected and General Population
Roht, L., Laidre, P., Tooming, M., Tõnisson, N., Nõukas, M., Nurm, M., Roomere, H., Rekker, K., Toome, K., Fjodorova, O., et al. (2023) · Cancers · doi:10.3390/cancers15143663 · Cited by 12
The Hedgehog/GLI signaling pathway activates transcription of Slug (Snail2) in melanoma cells
Horák, P., Kreisingerová, K., Réda, J., Ondrušová, Ľ., Balko, J., Achtenheim, J., Žáková, P., & Vachtenheim, J. (2023) · Oncology Reports · doi:10.3892/or.2023.8512 · Cited by 12
Zhao, H., He, L., Yin, D., & Song, B. (2019) · Oncology Letters · doi:10.3892/ol.2019.10724 · Cited by 10
Andréa, M. K., Jepsen, R. K., Klein, M. F., Gögenür, I., & Kühlmann, T. P. (2023) · Endoscopy International Open · doi:10.1055/a-2206-4486 · Cited by 9
Targeting non-coding RNA H19: A potential therapeutic approach in pulmonary diseases
Xie, J., Hu, Y.-D., Sun, D., Liu, C., Li, Z., & Zhu, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.978151 · Cited by 9
Response to osimertinib in a colorectal cancer patient with an EGFR T790M mutation: A case report
Buzard, B., Douglass, L., Gustafson, B., Buckley, J. L., Roth, M., Kujtan, L. A., & Bansal, D. (2023) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v15.i10.1829 · Cited by 9
Osman, H. M., & Tunçbilek, M. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210914121324 · Cited by 8
Barve, V., Adams, N., Stanbery, L., Manning, L., Horvath, S., Wallraven, G., Bognar, E., Barve, M. A., & Nemunaitis, J. J. (2021) · Vaccines · doi:10.3390/vaccines9101201 · Cited by 8
A genetic map of the chromatin regulators to drug response in cancer cells
Chen, B., Li, P., Liu, M., Liu, K., Zou, M., Geng, Y., Zhuang, S., Xu, H., Wang, L., Chen, T., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03651-w · Cited by 5
Self-citationWang, K., Olén, O., Emilsson, L., Khalili, H., Halfvarson, J., Song, M., & Ludvigsson, J. F. (2023) · International Journal of Cancer · doi:10.1002/ijc.34470 · Cited by 4
Segal, N. H., Tie, J., Kopetz, S., Ducreux, M. P., Chen, E., Dienstmann, R., Hollebecque, A., Reilley, M. J., Fernandez, M. E. E., Cosaert, J., et al. (2022) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2022.100272 · Cited by 3
on behalf of Oncology Network ASL1 Abruzzo, Bruera, G., Pepe, F., Malapelle, U., Staso, M. D., Mas, A. D., Giacomo, D. D., Scerbo, G., Santilli, M., Ciacco, E., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-6636 · Cited by 3
Lee, J. J., Yothers, G., George, T. J., Fakih, M., Mallick, A. B., Mitchell, E. P., Wade, J. L., Krauss, J. C., Kayaleh, O. R., Heron, D. E., et al. (2019) · Cancer Research · doi:10.1158/1538-7445.am2019-2257 · Cited by 2
Research works printed but not linked: 4
- Charifa, A., Jamil, R. T. & Zhang, X. Gardner syndrome. (2018). 29493967
- Garralda, E. et al. (Wolters Kluwer Health, 2021).
- Troyanska, O. & Reich, R. Pacific Symposium on Biocomputing 2022. World Sci, 175–186 (2022).
- Mnih, V., Heess, N. & Graves, A. Recurrent models of visual attention. Adv. Neural Inf. Process Syst. 2204–2212 (2014).
Cited by
Unveiling the link between chronic inflammation and cancer
Tripathi, S., Sharma, Y., & Kumar, D. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100347 · Cited by 109
Galasso, L., Termite, F., Mignini, I., Esposto, G., Borriello, R., Vitale, F., Nicoletti, A., Paratore, M., Ainora, M. E., Gasbarrini, A., et al. (2025) · Cancers · doi:10.3390/cancers17030368 · Cited by 90
Uti, D. E., Atangwho, I. J., Alum, E. U., Ntaobeten, E., Obeten, U. N., Bawa, I., Agada, S. A., Ukam, C. I.-O., & Egbung, G. E. (2025) · Discover Nano · doi:10.1186/s11671-025-04248-0 · Cited by 82
Bautista, J., Maceiras, M. L., Hidalgo‐Tinoco, C., Guerra-Guerrero, A., Betancourt-Velarde, A., & López‐Cortés, A. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00883-8 · Cited by 77
Pang, B., & Wu, H. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02623-5 · Cited by 79
Metadata
- Authors
- Li, Q., Geng, S., Luo, H., Wang, W., Mo, Y.-Q., Luo, Q., Wang, L., Song, G.-B., Sheng, J.-P., & Xu, B.
- Affiliations
- Chongqing University (CN)
- Chongqing Medical University (CN)
- Army Medical University (CN)
- Chongqing Municipal Health Commission (CN)
- Corresponding author
- Xu, Bo
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2024-10-07
- Volume
- 9
- Issue
- 1
- Pages
- 266-266
- ISSN
- 2059-3635 (ISSN-L)
- PMC
- PMC11456611
- OpenAlex
- W4403163174
- Cited by
- 546
- References
- 537
- Citations by year
- 2026: 275 · 2025: 263 · 2024: 7
- FWCI
- 29.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Signal Transduction and Targeted Therapy (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (61906022, 82203066)
- Topics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Keywords
- colorectal cancer, signal transduction, oncogenic signaling, colorectal cancer pathogenesis, colorectal cancer progression, targeted therapy, immunotherapy, epigenomics, microbiome, patient stratification
- MeSH terms
- Humans, Colorectal Neoplasms, Signal Transduction, Precision Medicine, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.